Insider Transactions in Q1 2022 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,998
-5.01%
|
$7,996
$2.78 P/Share
|
|
Feb 28
2022
|
Lisa Rojkjaer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,395
-5.62%
|
$4,790
$2.78 P/Share
|
|
Feb 28
2022
|
Ivor Royston |
SELL
Open market or private sale
|
Direct |
14,635
-2.43%
|
$29,270
$2.78 P/Share
|
|
Feb 25
2022
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+7.94%
|
-
|
|
Feb 25
2022
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+25.0%
|
-
|
|
Feb 25
2022
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,127
+8.83%
|
-
|
|
Feb 25
2022
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+4.01%
|
-
|